Ensho Therapeutics, Inc.
5 private offerings reported to the SEC on Form D since 2016, $35.2M sold in all. Biotech, New Jersey.
- Form D offerings: 5
- Reported sold: $35.2M
- Newest: Oct 15, 2026
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Oct 15, 2026 | — | $7.3M | $15.6M | Ensho Therapeutics, Inc.Biotech · New Jersey | Not amended | 0002032849-26-000002 |
| Feb 9, 2026 | — | None yet | $20.0M | Ensho Therapeutics, Inc.Biotech · New Jersey | Not amended | 0002032849-26-000001 |
| Sep 12, 2025 | — | $22.5M | $22.5M | Ensho Therapeutics, Inc.Biotech · New York | Not amended | 0002032849-25-000003 |
| Nov 12, 2024 | — | $5.0M | $12.5M | Ensho Therapeutics, Inc.Biotech · New York | Not amended | 0002032849-24-000002 |
| Aug 6, 2024 | — | $400K | $2.0M | Ensho Therapeutics, Inc.Biotech · New York | Not amended | 0002032849-24-000001 |
- Business address
- Morris Plains, NY
- Incorporated in
- Delaware
- All SEC filings
- CIK 2032849 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR